Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pathophysiology of bone metastases].

Daniel Chappard1, Erick Legrand, Philippe Massin

  • 1INSERM EMI 0335-LHEA, Faculté de Médecine, 49045 Angers, France. daniel.chappard@univ-angers.fr

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|June 21, 2003
PubMed
Summary

This review details bone metastasis mechanisms, explaining the "vicious circle" between tumor and bone cells. Understanding these interactions supports using anti-osteoclastic treatments for bone lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeated unilateral injections of botulinum toxin in masticatory muscles in adult rats do not amplify condylar and alveolar bone loss nor modify the volume of the hypertrophic bone proliferation at enthesis.

Journal of stomatology, oral and maxillofacial surgery·2024
Same author

Differences in bone microarchitecture between genetic and secondary iron-overload mouse models suggest a role for hepcidin deficiency in iron-related osteoporosis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2023
Same author

1st EFORT European Consensus "Medical & Scientific Research Requirements for the Clinical Introduction of Artificial Joint Arthroplasty Devices": Background, Delphi Methodology & Consensus process.

EFORT open reviews·2023
Same author

Development of a First-in-Class Unimolecular Dual GIP/GLP-2 Analogue, GL-0001, for the Treatment of Bone Fragility.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2023
Same author

(-)-Epigallocatechin gallate (EGCG) pharmacokinetics and molecular interactions towards amelioration of hyperglycemia, hyperlipidemia associated hepatorenal oxidative injury in alloxan induced diabetic mice.

Chemico-biological interactions·2022
Same author

ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?

Experimental dermatology·2022

Area of Science:

  • Oncology
  • Pathophysiology
  • Bone Biology

Context:

  • Bone metastases involve malignant cells from primary tumors colonizing bone marrow.
  • This review focuses on osteolytic and osteosclerotic bone metastases, excluding hematologic malignancies.
  • The pathophysiology involves complex cytokine networks and cellular interactions within the bone microenvironment.

Purpose:

  • To elucidate the pathophysiologic mechanisms underlying bone metastases.
  • To describe the interplay between tumor cells and bone cells in metastasis.
  • To explain the rationale behind anti-osteoclastic therapies in bone metastases.

Summary:

  • Malignant cells invade bone marrow, leading to osteolytic (bone-resorbing) or osteosclerotic (bone-forming) metastases.

Related Experiment Videos

  • A critical "vicious circle" exists between tumor cells and bone cells, disrupting normal bone remodeling.
  • Cytokine networks mediate these interactions, driving disease progression and bone destruction or formation.
  • Impact:

    • Provides a comprehensive understanding of bone metastasis pathophysiology.
    • Highlights the therapeutic potential of targeting the tumor-bone cell crosstalk.
    • Informs the clinical application of anti-osteoclastic agents like bisphosphonates for managing bone metastases.